FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elinor Ben-Menachem

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Vagus Nerve

Concepts & Ideas

Procedures

Living Beings

Co-author Network

Publications

TOP 3
Elinor Ben-Menachem
Neurostimulation-past, present, and beyond.
Kristl Vonck; Veerle de Herdt; Mathieu Sprengers; Elinor Ben-Menachem
Neurostimulation for epilepsy.
Elinor Ben-Menachem; J W Sander
Vigabatrin therapy for refractory complex partial seizures: review of major European trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elinor Ben-Menachem (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Elinor Ben-Menachem
Neurostimulation-past, present, and beyond.
Epilepsy currents / American Epilepsy Society 2012;12(5):188-91.
2012: Kristl Vonck; Veerle de Herdt; Mathieu Sprengers; Elinor Ben-Menachem
Neurostimulation for epilepsy.
Handbook of clinical neurology 2012;108():955-70.
2011: Elinor Ben-Menachem; J W Sander
Vigabatrin therapy for refractory complex partial seizures: review of major European trials.
Acta neurologica Scandinavica. Supplementum 2011;(192):16-28.
2011: Elinor Ben-Menachem
Mechanism of action of vigabatrin: correcting misperceptions.
Acta neurologica Scandinavica. Supplementum 2011;(192):5-15.
2010: Linda Paulson; Asa Persson; Kristl Vonck; Annelies Van Dycke ; H Georg Kuhn; Paul Boon; Elinor Ben-Menachem; Robrecht Raedt
Effect of levetiracetam on hippocampal protein expression and cell proliferation in rats.
Epilepsy research 2010;90(1-2):110-20.
2010: Gregory Krauss; Elinor Ben-Menachem; Ruta Mameniskiene; Nerija Vaiciene-Magistris; Melissa Brock; John G Whitesides; Martin E Johnson
Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures.
Epilepsia 2010;51(6):951-7.
2010: Elinor Ben-Menachem; Josemir W Sander; Michael Privitera; Frank Gilliam
Measuring outcomes of treatment with antiepileptic drugs in clinical trials.
Epilepsy & behavior : E&B 2010;18(1-2):24-30.
2010: Elinor Ben-Menachem; A A Gabbai; A Hufnagel; J Maia; Luis Almeida; P Soares-da-Silva
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Epilepsy research 2010;89(2-3):278-85.
2009: Elinor Ben-Menachem
Introduction--Annual Course 2008: American Epilepsy Society.
Epilepsia 2009;50 Suppl 8():1-2.
2008: David Revesz; Mikael Tjernstrom; Elinor Ben-Menachem; Thorleif Thorlin
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation.
Experimental neurology 2008;214(2):259-65.
2008: Elinor Ben-Menachem; Carsten Wikkelsö
Retraction. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Acta neurologica Scandinavica 2008;118(3):208.
2008: Elinor Ben-Menachem
Outcomes remain ambivalent for deep brain stimulation and epilepsy.
Epilepsy currents / American Epilepsy Society 2008;8(5):121-3.
2008: Elinor Ben-Menachem; Josemir W. Sander; Hermann Stefan; Susanne Schwalen; Barbara Schäuble
Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
Clinical therapeutics 2008;30(7):1180-95.
2008: Elinor Ben-Menachem
Seizure aggravation-evidence that oxcarbazepine requires monitoring.
Epilepsy currents / American Epilepsy Society 2008;8(4):93-5.
2008: Elinor Ben-Menachem
Is topiramate tops?
Epilepsy currents / American Epilepsy Society 2008;8(3):60-1.
2008: Elinor Ben-Menachem
Strategy for utilization of new antiepileptic drugs.
Current opinion in neurology 2008;21(2):167-72.
2008: Elinor Ben-Menachem
Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
Drugs of today (Barcelona, Spain : 1998) 2008;44(1):35-40.
2007: Elinor Ben-Menachem
Retigabine: has the orphan found a home?
Epilepsy currents / American Epilepsy Society 2007;7(6):153-4.
2007: Peter W Kaplan; Errol R Norwitz; Elinor Ben-Menachem; Page B Pennell; Maurice L Druzin; Julian N Robinson; Jacki C Gordon
Obstetric risks for women with epilepsy during pregnancy.
Epilepsy & behavior : E&B 2007;11(3):283-91.
2007: Robrecht Raedt; Paul Boon; Asa Persson; Ann-Marie Alborn; Tom Boterberg; Annelies Van Dycke ; Birgit Linder; Tim De Smedt; Wytse J Wadman; Elinor Ben-Menachem; Peter S Eriksson
Radiation of the rat brain suppresses seizure-induced neurogenesis and transiently enhances excitability during kindling acquisition.
Epilepsia 2007;48(10):1952-63.
2007: Elinor Ben-Menachem; Victor Biton; Dalius Jatuzis; Bassel Abou-Khalil; Pamela Doty; G David Rudd
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.
Epilepsia 2007;48(7):1308-17.
2007: Torbjörn Tomson; Ragnar Palm; Kristina Källén; Elinor Ben-Menachem; Birgitta Söderfeldt; Bengt R Danielsson; Rune Johansson; Gerhard Luef; Inger Ohman
Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Epilepsia 2007;48(6):1111-6.
2007: Elinor Ben-Menachem
Weight issues for people with epilepsy--a review.
Epilepsia 2007;48 Suppl 9():42-5.
2006: Charley A Merrill; Michael Jonsson; Lennart Minthon; Hasse Ejnell; Hans C-son Silander; Kaj Blennow; Mats Karlsson; Arto Nordlund; Sindre Rolstad; Siegbert Warkentin; Elinor Ben-Menachem; Magnus Sjögren
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
The Journal of clinical psychiatry 2006;67(8):1171-8.
2006: Tracy A Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; David W Chadwick; Carlos Guerreiro; Reetta Kalviainen; Richard H Mattson; Emilio Perucca; Torbjorn Tomson
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Epilepsia 2006;47(7):1094-120.
2006: Elinor Ben-Menachem
Is prolactin a clinically useful measure of epilepsy?
Epilepsy currents / American Epilepsy Society 2006;6(3):78-9.
2006: Elinor Ben-Menachem; Jacqueline A French
Guidelines--are they useful?
Epilepsia 2006;47 Suppl 1():62-4.
2006: Svein I Johannessen; Elinor Ben-Menachem
Management of focal-onset seizures: an update on drug treatment.
Drugs 2006;66(13):1701-25.
2005: Elinor Ben-Menachem
Sudden death and epilepsy.
Epilepsy currents / American Epilepsy Society 2005;5(6):223-4.
2005: Elinor Ben-Menachem; Jacqueline A French
VNS Therapy versus the latest antiepileptic drug.
Epileptic disorders : international epilepsy journal with videotape 2005;7 Suppl 1():S22-6.
2005: Mikael Angehagen; Lars Rönnbäck; Elisabeth Hansson; Elinor Ben-Menachem
Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures.
Journal of neurochemistry 2005;94(4):1124-30.
2005: Elinor Ben-Menachem
Infantile spasms and epilepsy currents.
Epilepsy currents / American Epilepsy Society 2005;5(4):157-8.
2005: Elinor Ben-Menachem
The importance of increased clearance of lamotrigine during pregnancy.
Epilepsy currents / American Epilepsy Society 2005;5(2):59-60.
2005: Stephen D Silberstein; Elinor Ben-Menachem; Richard P Shank; Frank Wiegand
Topiramate monotherapy in epilepsy and migraine prevention.
Clinical therapeutics 2005;27(2):154-65.
2005: Elinor Ben-Menachem
Epilepsy as a warning sign for stroke.
Epilepsy currents / American Epilepsy Society 2005;5(1):42-3.
2005: Elinor Ben-Menachem
AAN/AES guidelines on use of new AEDS.
Epilepsy currents / American Epilepsy Society 2005;5(1):30-2.
2004: Elinor Ben-Menachem
Toward a more pragmatic view of driving and epilepsy.
Epilepsy currents / American Epilepsy Society 2004;4(4):133-4.
2004: Elinor Ben-Menachem
Pregabalin pharmacology and its relevance to clinical practice.
Epilepsia 2004;45 Suppl 6():13-8.
2004: Mikael Angehagen; Elinor Ben-Menachem; Richard Shank; Lars Rönnbäck; Elisabeth Hansson
Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level.
Journal of neurochemistry 2004;88(2):320-5.
2003: Ettore Beghi; Giuliana Gatti; Clara Tonini; Elinor Ben-Menachem; David W Chadwick; Marina Nikanorova; Sergei A Gromov; Philip E M Smith; Luigi Maria Specchio; Emilio Perucca
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial.
Epilepsy research 2003;57(1):1-13.
2003: Elinor Ben-Menachem
Levetiracetam: treatment in epilepsy.
Expert opinion on pharmacotherapy 2003;4(11):2079-88.
2003: Elinor Ben-Menachem
Preliminary efficacy of levetiracetam in monotherapy.
Epileptic disorders : international epilepsy journal with videotape 2003;5 Suppl 1():S51-5.
2003: Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures.
Epilepsy research 2003;54(1):63-71.
2003: Elinor Ben-Menachem; Mette Axelsen; Else Hellebö Johanson; Anna Stagge; Ulf Smith
Predictors of weight loss in adults with topiramate-treated epilepsy.
Obesity research 2003;11(4):556-62.
2003: Elinor Ben-Menachem; Eric Gilland
Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
Seizure : the journal of the British Epilepsy Association 2003;12(3):131-5.
2003: Mikael Angehagen; Doru Georg Margineanu; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson; Henrik Klitgaard
Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons.
Neuroreport 2003;14(3):471-5.
2003: Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.
Neurochemical research 2003;28(2):333-40.
2003: Elinor Ben-Menachem; Pascal Edrich; Betty Van Vleymen; Josemir W. Sander; Bernd Schmidt
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
Epilepsy research 2003;53(1-2):57-64.
2002: Elinor Ben-Menachem
Vagus-nerve stimulation for the treatment of epilepsy.
Lancet neurology 2002;1(8):477-82.
2002: Magnus Sjögren; Per T O Hellström; Michael Jonsson; Magnus Runnerstam; Hans C-Son Silander; Elinor Ben-Menachem
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study.
The Journal of clinical psychiatry 2002;63(11):972-80.
2002: Elinor Ben-Menachem; Karin Hellström; Daniel Verstappen
Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients.
Neurology 2002;59(6 Suppl 4):S44-7.
2001: Elinor Ben-Menachem
Proof of efficacy trials: seizure types.
Epilepsy research 2001;45(1-3):31-4; discussion 35-6.
2000: Elinor Ben-Menachem; Ursula Falter
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
Epilepsia 2000;41(10):1276-83.
2000: Elinor Ben-Menachem; Mårten Kyllerman; S Marklund
Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies.
Epilepsy research 2000;40(1):33-9.
1999: Elinor Ben-Menachem; Karin Hellström; C Waldton; LE Augustinsson
Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years.
Neurology 1999;52(6):1265-7.
1999: Elinor Ben-Menachem
The role of new antiepileptic drugs.
Advances in neurology 1999;81():317-21.
1998: Mårten Kyllerman; Elinor Ben-Menachem
Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients.
Epilepsy research 1998;29(2):109-14.
1997: Elinor Ben-Menachem
Topiramate: current status and therapeutic potential.
Expert opinion on investigational drugs 1997;6(8):1085-94.
1996: Elinor Ben-Menachem
Modern management of epilepsy: Vagus nerve stimulation.
Baillière's clinical neurology 1996;5(4):841-8.
1996: Elinor Ben-Menachem
Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents.
Epilepsia 1996;37 Suppl 2():S4-S7.
1995: Elinor Ben-Menachem; B Söderfelt; Anders Hamberger; Thomas Hedner; L I Persson
Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
Epilepsy research 1995;21(3):231-6.
1995: Elinor Ben-Menachem; Anders Hamberger; Thomas Hedner; E J Hammond; Basim M Uthman; J Slater; T Treig; H Stefan; R Eugene Ramsay; J F Wernicke
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.
Epilepsy research 1995;20(3):221-7.
1994: Elinor Ben-Menachem; R Mañon-Espaillat; R Ristanovic; B J Wilder; H Stefan; W Mirza; W B Tarver; J F Wernicke
Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group.
Epilepsia 1994;35(3):616-26.
1993: Elinor Ben-Menachem; Anders Hamberger; J Mumford
Effect of long-term vigabatrin therapy on GABA and other amino acid concentrations in the central nervous system--a case study.
Epilepsy research 1993;16(3):241-3.
1992: C Nordborg; Elinor Ben-Menachem; Mårten Kyllerman
Neurovascular microdysgenesis in a case of Unverricht-Lundborg's disease.
Epilepsy research 1992;13(2):121-7.
1992: E J Hammond; Basim M Uthman; B J Wilder; Elinor Ben-Menachem; Anders Hamberger; T Hedner; R Ekman
Neurochemical effects of vagus nerve stimulation in humans.
Brain research 1992;583(1-2):300-3.
1992: Elinor Ben-Menachem; L I Persson; Thomas Hedner
Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
Epilepsy research 1992;11(1):45-9.
1992: J Lycke; Oluf Andersen; Bo Svennerholm; Elinor Ben-Menachem; Peter Horal; A Vahlne
Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
Acta neurologica Scandinavica 1992;85(1):44-54.
1991: Elinor Ben-Menachem; L I Persson
Reproducibility of monoamine metabolites in human CSF.
Acta neurologica Scandinavica 1991;83(3):204-5.
1991: Elinor Ben-Menachem; L I Persson; J Mumford; K D Haegele; N Huebert
Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
Journal of child neurology 1991;Suppl 2():S11-6.
1990: L I Persson; Elinor Ben-Menachem; E Bengtsson; E Heinonen
Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
Epilepsy research 1990;6(2):134-40.
1990: Elinor Ben-Menachem; L Persson; J Mumford
Long-term evaluation of once daily vigabatrin in drug-resistant partial epilepsy.
Epilepsy research 1990;5(3):240-6.
1989: Elinor Ben-Menachem; L Persson; P J Schechter; K D Haegele; N Huebert; J Hardenberg
Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures.
Journal of neurochemistry 1989;52(2):632-5.
1989: Elinor Ben-Menachem
Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans.
Epilepsia 1989;30 Suppl 3():S12-4.
1989: L I Persson; L Rönnbäck; Elinor Ben-Menachem; P Eriksson; M Nilsson
Changes in CSF and brain soluble proteins following vigabatrin treatment in rats.
British journal of clinical pharmacology 1989;27 Suppl 1():73S-77S.
1989: Elinor Ben-Menachem; L I Persson; P J Schechter; K D Haegele; N Huebert; J Hardenberg; Lars Owe Dahlgren; J P Mumford
The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
British journal of clinical pharmacology 1989;27 Suppl 1():79S-85S.